Profile
Our mission is to deliver superior value to our investors and companies by forming collaborative partnerships that produce operational excellence and innovation.
Thoma Bravo is a leading private equity firm with a 40+ year history, including over $83 billion in assets under management as of June 30, 2021, and a focus on investing in software and technology companies. We pioneered the buy-and-build investment strategy, and we first applied this strategy to the software and technology industries 20+ years ago. Since then, our firm has acquired more than 325 software and technology companies representing over $100 billion of value. Our investment philosophy is centered around working collaboratively with existing management teams to help drive operating results and innovation. We execute through a partnership-driven approach supported by a set of management principles, operating metrics and business processes. We support our companies by investing in growth initiatives and strategic acquisitions designed to drive long-term value.
Industry
Region of investment
Thoma Bravo Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Thoma Bravo Explore Fund II
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Security
Software
Technology
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$1800 M
|
December 2022
|
|
Thoma Bravo Discover Fund IV
|
Private Equity (PE)
|
Healthcare Services
SaaS
Security
Software
Technology
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$6200 M
|
December 2022
|
|
Thoma Bravo Fund XV
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
SaaS
Security
Software
Technology
Energy
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$24000 M
|
December 2022
|
|
Thoma Bravo Europe Fund I
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
SaaS
Security
Software
Technology
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1800 M
|
February 2025
|
|
Thoma Bravo Fund XVI
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
SaaS
Security
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$24000 M
|
June 2025
|
|
Thoma Bravo Discover Fund V
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
SaaS
Security
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$8100 M
|
June 2025
|